{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/cfDNA",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0199"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_3676"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/733691"
      },
      "sc:description": "> LOW CONFIDENCE! | > CORRECT NAME OF TOOL COULD ALSO BE 'assay' | Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing | Analysis of cfDNA data with UMIs (consensus generation, SNV calling, annotation and evaluation of fragment length profiles) | Detection of genomic alterations with error-corrected cfDNA sequencing | Several recent studies have demonstrated the ability of cfDNA sequencing to provide early prognostication, better molecular profiling and monitoring of disease dynamics with many applications in genomic-driven oncology",
      "sc:license": "MIT",
      "sc:name": "cfDNA",
      "sc:url": "https://github.com/dkleftogi/cfDNA_AnalysisPipeline"
    },
    {
      "@id": "https://doi.org/10.1101/733691",
      "@type": "sc:CreativeWork"
    }
  ]
}